Interview at the American Society of Echocardiography (ASE) annual meeting with Federico Asch, M.D., M.D., FACC, FASE, associate director of the echocardiography core lab at Medstar Health Research Institute and assistant professor of medicine (cardiology) at Georgetown University. He explains how ultrasound might have a roll in the future for breaking up clots and targeted delivery of gene and drug therapies.
Videos
DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings
In this segment of our DAIC Thought Leadership Series, which features one-on-one conversations with cardiovascular leaders, we're talking with Dr. Jeffrey Soble. He serves both as a practicing cardiologist at Rush University Medical Group’s Cardiology Intensive Care Unit, and CEO of Ascend Cardiovascular. in this video he addresses some of the challenges related to collaborating in complex cardiology settings, and provides insight into ways telepresence and augmented reality can be used — from a clinical perspective, using a holistic approach to structured reporting.
Cardiac Imaging
Interview with Steve Goldstein, M.D., director, noninvasive lab, Medstar Washington Heart Institute, Washington, D.C., on the uses of echo guidance for interventional procedures in the cath lab. He spoke with DAIC Editor Dave Fornell at ASE 2015.
Role of Interventional Echcardiography in Transcatheter Structural Heart Procedures — Rebecca Hahn, M.D., Columbia University Medical Center, is an expert in the new subspecialty of interventional echo and shares her insights at the Cardiovascular Research Foundation's (CRF) Transcatheter Valve Therapies (TVT) conference in Chicago in June.
Interview with Ted Feldman, M.D., FACC, MSCAI, FESC, cardiac cath lab director, Evanston Hospital, North Shore Health System, and principle investigator, Everest II MitraClip U.S. pivotal trial, at the Transcatheter Valve Therapies 2015 meeting. Watch the VIDEO “Advances and Future Directions for Transcatheter Valves.”
Treating Mitral Regurgitation in High Risk PatientsUsing the MitraClip — article by Allen Atchley, M.D.
Interview with Juan Granada, M.D., executive director and chief scientific officer of the Cardiovascular Research Foundation's Skirball Center for Innovation, at the Transcatheter Valve Therapies 2015 meeting. Read the article "Transcatheter Mitral Valve Replacement Devices in Development."
Many of the key trends in radiology seen at the Radiological Society of North America (RSNA) 2014 meeting are discussed by ITN Contributing Editor Greg Freiherr and ITN Editor Dave Fornell.
Here are ITN Editor Dave Fornell's choices for the most innovative new imaging technologies shown on the expo floor at the Radiological Society of North America (RSNA) 2014 annual meeting.
Siemens introduces True volume transesophageal echo (TEE) transducer — this 3-D/4-D 90°x90° TEE solution enables clinically meaningful echocardiography visualization of anatomy, volume color Doppler and function in one volume view, without compromises like stitching. Combined with eSieValves advanced cardioac ultrasound analysis package, it offers automated modeling and quantification in seconds allowing cardiologists to remove the guesswork from valve sizing. For more information: usa.healthcare.siemens.com/ultrasound/cardiovascular/acuson-sc2000-ultrasound-system/features
John Stevens, chairman and CEO of HeartFlow, explains his company's computed tomography (CT)-based fractional flow reserve (FFR) assessment technology, which may eliminate the need for catheter-based FFR measurements.
Toshiba launched its new myocardial perfusion software for computed tomography (CT) during the 2014 American College of College of Cardiology (ACC) annual meeting. Perfusion imaging is now available on both the Aquillion One and Aqullion One Vision CT systems.
DAIC Editor Dave Fornell explains some of the most innovative new cardiovascular CT technology displayed at the Society of Cardiovascular Computed Tomography (SCCT) 2014.
Society of Cardiovascular Computed Tomography (SCCT) Past President Matthew Budoff, M.D., explains some of the new technology and latest trends seen in cardiac CT during the SCCT 2014 annual meeting in San Diego, Calif.
The Aplio 500 CV is the system of choice for all premium 2-D cardiac exams. Featuring Toshiba's 2-D Wall Motion Tracking technology, the system provides stunning visualization and quantitative analysis of myocardial wall motion with unrivaled accuracy and reproducibility. With on-board cardiac quantification measurements in all directions (radial, circumferential, 2D rotation and longitudinal), the Aplio 500 CV system is designed to get the most comprehensive information anytime and anywhere in the hospital, right at the patient's bedside. Additional cardiac-specific technologies include Tissue Enhancement, Advanced Dynamic Flow, Lateral Gain Controls, Tissue Doppler, Stress Echo, Flex-M Mode and Auto IMT. The system is easy to use, with superior ergonomics and a smaller footprint, making it easier to maneuver for greater patient access and improved workflow. For more information: http://medical.toshiba.com/products/ul/cardiovascular/index.php
DAIC Editor Dave Fornell highlights his choices for some of the most innovative new technology at the American Society of Echocardiography (ASE) 2014 meeting.
ASE Past President James Thomas, M.D., explains some of the hot topics in cardiovascular ultrasound at the 2014 meeting of the American Society Echocardiography (ASE).
DAIC Editor Dave Fornell shares his choices for the most innovative new technologies in nuclear imaging that were on display at the 2014 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
Satoshi Minoshima, M.D., Ph.D., chairman of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Scientific Committee, discusses the new technologies and trends at the SNMMI 2014 meeting.
DAIC Editor Dave Fornell offers his choices of the most innovative new cardiovascular technologies shown on the expo floor at the American College of Cardiology (ACC) 2014 meeting.
GE Healthcare is dedicated to helping healthcare organizations build a roadmap for a comprehensive radiation dose management strategy. Learn about current trends in dose management and how GE Healthcare's DoseWatch solution can help you. Read the article "The Role of Dose Tracking Systems in Radiation Safety Programs."
Hear why Siemens SOMATOM Definition Edge is the CT your emergency department (ED) has been dreaming about from the leadership at Gwinett Medical Center. From physicians to the C-suite, see why the Edge is helping them meet their most demanding and time sensitive imaging needs with low-dose and high image quality.
DAIC Editor Dave Fornell offers his choices of the most innovative new cardiovascular technologies discussed in sessions and shown on the expo floor at the Transcatheter Cardiovascular Therapeutics (TCT) 2013 meeting.
Scott Lim, M.D., director of the Heart Valve Center at the University of Virginia Medical Center, investigator in the EVEREST and COAPT trials, discusses the MitraClip transcatheter mitral valve repair system at TCT 2013. The device recieved FDA clearance a couple days before TCT.
Read the article "FDA Clears First Transcatheter Mitral Valve Repair Device."
American Society of Echocardiography (ASE) President Benjamin Byrd III, M.D., FASE, explains some of the recent trends and issues facing cardiac ultrasound. These trends include reimbursement issues, the rapid expansion of point-of-care ultrasound and the critical role played by the new sub-specialty of interventional ultrasound.
DAIC Editor Dave Fornell highlights some of the biggest trends and most innovative technology discussed during the American Society of Echocardiology (ASE) 2013 annual meeting.
The American College of Cardiology (ACC) 2013 Scientific Session Committee Chairman Miguel Quinones, M.D., explains some of the key highlights from this year's meeting. Highlights included the impact of niacin on lowering cholesterol, new data on transcatheter aortic valve repair, and how mummies show atherosclerosis is not a modern disease.
DAIC Editor Dave Fornell explains his choices for the most innovative new technology on the expo floor at the American College of Cardiology (ACC) 2013. These include new angiography systems, dose monitoring software and technology integrations, an iPhone ECG monitoring device, ultrasound-aided CRT lead optimization, and new radiation protection aprons that are up to 50 percent lighter.
The Iowa Heart Center created a telecardiology program that connects cardiologists in Des Moines with satellite facilities in rural towns around the state. With help from Esaote, patients can have their echo exams performed on a compact ultrasound system and delivered to Des Moines for review by experts. Iowa Heart will detail its program during sessions at ACC.2013, March 9-11, in San Francisco.
This short cine loop shows a 3-D/4-D transesophegeal echo (TEE) view of a transcatheter Amplatzer closure device used to seal an atrial septal defect (ASD) and the operation of a surgically implanted St. Jude Medical mechanical mitral valve. This type of complex ASD transcatheter repair is much easier to perform under real-time 3-D TEE guidance. This image was provided by GE Healthcare's Vivid E9 Breakthrough 2012 (BT12), which includes a 4-D transducer for TEE.
At RSNA 2012, Hitachi featured its Echelon Oval 1.5T MRI system, which features the widest bore on the market at 74 cm, a wide table and the ability to perform non-contrast MR angiography exams. Hitachi also highlighted new features for its Scenaria CT system, which is upgradeable to a 128-slice system, offers new, faster iterative reconstruction software and cardiac imaging packages.
DAIC Editor Dave Fornell highlights the latest advancements that will impact cardiovascular imaging from the 2012 Radiological Society of North America (RSNA) meeting. RSNA is the largest medical imaging show in the world and most advancements are shown here first.
Imaging Technology News experts discuss the trends and latest technology they saw on the show floor and in sessions at RSNA 2012. Their discussions include some of the most innovative new devices and software to solve issues facing radiology today.
Mercy Hospital in Chicago has developed a successful hybrid cath lab program where various specialties work together for the best, minimally invasive patient outcomes. Beyond the coronaries, this cath lab specializes in endovascular aortic stent grafting, peripheral vascular disease, embolization procedures and transcatheter heart valve replacements. Read the related article "Most Innovative Heart Centers: Chicago’s Mercy Hospital." Watch the related Mercy VIDEO "Mercy Hospital Develops Effective, Collaborative Interventional Program."
Mercy Hospital in Chicago developed an interventional program around its hybrid cath labs, fostering collaboration between interventional cardiologists, vascular surgeons and interventional radiologists. This collaboration has helped the hospital improve care and keep costs low in order to serve the Chicago South Side's low-income population. Read the article "Most Innovative Heart Centers: Chicago’s Mercy Hospital." There is also a related VIDEO about Mercy, "Developing a Hybrid Cath Lab Program."
Results from the POSEIDON Trial were presented at Transcatheter Cardiovascular Therapeutics (TCT) 2012. Data showed a positive strategy to prevent contrast-induced nephropathy (CIN) in patients with renal impairment undergoing interventional catheterization procedures. CIN is also referred to as acute kidney injury (AKI). The data is presented in a press conference by Sonjot Brar, M.D., MPH, Kaiser Permanente.
Related CIN Content:
Sliding Scale Hydration Washes Out Contrast-Induced Kidney Complications
Contrast-Induced Kidney Injury Prevented With RenalGuard in REMEDIAL III Trial
VIDEO: How to Avoid Acute Kidney Injury in the Cath Lab — Interview with Hitinder Gurm, M.D.
VIDEO: Strategies to Avoid Acute Kidney Injury Caused by Cath Lab Contrast — Interview with Roxana Mehran, M.D.
Diagnostic and Interventional Cardiology Editor Dave Fornell shares his choices of the latest advances in cardiac ultrasound from the show floor of the American Society of Echocardiography (ASE) 2012. With the increasing use of more complex interventional procedures, transesophageal echo (TEE) and intracardiac echo (ICE) are being used for guidance to reduce fluoroscopic radiation dose.
Three big trends were seen in cardiovascular ultrasound during the American Society of Echocardiography (ASE) 2012 meeting. Malissa Wood, M.D., co-director of the Women's Center at Mass General Hospital, Boston, and chair of the ASE Public Relations Committee, explains these trends. The biggest is the expanding use of ultrasound and transesophageal echo (TEE) in the cath lab and hybrid OR for structural heart procedural navigation. Other trends include use of pocket ultrasound and new software advances to simlify and reduce the time it takes to use 3-D echo and make quantifications. For more information: www.dicardiology.com/article/ultrasound-sees-increasing-use-interventional-procedures
Siemens' syngo Aortic ValveGuide software enables transcatheter aortic valve replacement (TAVR) procedural guidance with integration of 3-D images on live fluoro imaging. This video shows the valve guidance technology used during the implantation of a Medtronic CoreValve device. For more information: www.DIcardiology.com
The ACRIN-PA trial showed computed tomography (CT) coronary angiography can be more cost-effective than the standard-of-care in evaluating patients with chest pain in the emergency department. The data was presented by Harold Litt, M.D., during the American College of Cardiology (ACC) 2012 scientific sessions. For more information: www.DIcardiology.com
Related ACRIN-PA Study Content:
VIDEO: CT for Chest Pain Evaluation in The Emergency Department — Interview with Harold Litt, M.D.
VIDEO: ACRIN-PA Trial Showed Benefit of CT in Assessing Chest Pain — Litt explaining the trial.
Coronary CT Angiography is Effective to Evaluate Chest Pain Patients
One of the most interesting educational exhibits at the recent American College of Cardiology (ACC) 2012 Scientific Session was "The Heart of Innovation" display on the show floor. The ACC in collaboration with marquee sponsor Philips Healthcare and several other industry leaders created this non-accredited, hands-on education experience. The exhibit explored the evolution of the standard-of-care for heart disease and heart failure caused by valvular disease. It looked at these issues through the lenses of personalized medicine, techno-biology, minimally invasive procedures and physician-patient engagement. The exhibit included technology from the past, present and future of healthcare. To incorporate a historical view, the entrance to the display included the ACC's special collection of historic artifacts encompassing medical books, stethoscopes and device technology dating back hundreds of years, including a stethoscope from 1535. This historical perspective was juxtaposed with a modern attendee experience that included the option to explore the entire exhibit with a specially provided iPad tour. The centerpiece was a mockup of a hybrid OR. It included a Corindus CorPath robotic cath lab intervention guidance system. Other partners included Maquet, showing a portable heart-lung machine the size of a small suitcase and the CFI Medical Solutions ZeroGravity radiation protection system. What made the hybrid OR particularly unique was that it was situated across from the Minimally Invasive Gallery, which featured many of the innovations that are driving procedures performed in the hybrid OR. The gallery encompassed solutions from Medtronic and Edwards Lifesciences, including Edward's breakthrough Sapien transcatheter heart valve. The display discussed current treatments and what the future technologies will likely be from the standard-of-care in the future.
Siemens' AcuNav V 3-D intracardiac echo (ICE) catheter offers detailed, live 3-D images of the interior of the heart. This video shows an example of the catheter imaging the left atrial appendage (LAA). The technology may play a role in guiding and properly seating transcatheter LAA occluders. The technology was shown as a work-in-progress during ACC 2012.